Exploring the Future of Healthcare: Precision Medicine, AI Security, and More in Our Latest Newsletter!
Dive into our latest newsletter featuring the promise of precision medicine, generative AI security, patient targeting webinar alert, and exciting company updates. Discover transformative impacts, strategic recommendations, and valuable insights across diverse areas of healthcare and life sciences.?
WEBINAR ALERT:?
Patient Targeting for Biopharma: Strategies for Pharma Marketers?
Date & Time: Feb 27, 12:00-12:45 EST
Join our upcoming webinar: "Patient Targeting for Biopharma: Strategies for Pharma Marketers" on Tue, Feb 27, 2024, at 12:00-12:45 EST. Gain actionable insights to enhance your brand's impact and unlock invaluable takeaways including effective patient segmentation, strategic insights, and actionable brand development. Don't miss out - register now to propel your biopharma brand to new heights!?
In this webinar, you'll gain 3 invaluable takeaways:?
HCP-PT:?
The Promise of Precision Medicine: Gene Therapies Bringing Hope to Rare Disease Management?
In this blog, ZoomRx explores the transformative impact of gene therapy and CAR-T therapy on rare diseases. The blog delves into real-world HCP-patient conversations, showcasing the potential of these novel therapies through point-of-care dialogues for patients with Hemophilia and Diffuse Large B Cell Lymphoma. It highlights patient enthusiasm and trust in their doctors, as well as the challenges and limitations faced in introducing these innovative treatments. The blog also emphasizes the role of HCP-patient conversation research in enabling life science companies to understand patient perceptions and improve patient outcomes.?
领英推荐
Ferma Engine:?
Generative AI Security: Preparing Your IT Infrastructure for the Next Big Thing?
The blog discusses the rapid evolution of generative AI in the life sciences industry, emphasizing the need for a balance between innovation and data security. It offers five strategic recommendations for responsibly integrating generative AI, including prioritizing data security, building trust and transparency, incorporating expertise and contextual understanding, evaluating model deployment options, and emphasizing the importance of employee training. By following these recommendations, organizations can benefit from AI's capabilities while maintaining stakeholder trust and data integrity.?
Endpoint News Article:?
ZoomRx: Your Trusted Partner in Navigating the Evolving Media Landscape for Pharma Ads?
A recent Endpoints News article highlighted the stricter enforcement of Meta's ad policies, resulting in the removal of several pharma ads, including those from Sanofi, Gilead, and ViiV Healthcare. Despite the reasons behind this heightened scrutiny remaining unclear, ZoomRx's expertise in comprehending the complexities of navigating the dynamic social media advertising landscape for the pharmaceutical industry was underscored.?
Don't let these stricter ad policies impede your pharma marketing efforts on social media. Partner with ZoomRx to leverage our experience and expertise in confidently navigating this evolving landscape.?
For more information, you can visit the Endpoints News website ?
Press Release:?
ZoomRx Welcomes Brian Gibbs as Principal of Commercial Analytics?
ZoomRx is proud to announce the arrival of Brian Gibbs, Ph.D., as the Principal of Commercial Analytics. With over two decades of experience in biopharma Commercial Analytics consulting, Brian's expertise will enhance our capabilities and provide unparalleled strategic consulting services to our life sciences partners. His proven track record in delivering innovative solutions and his deep expertise in uncovering actionable insights will undoubtedly contribute to ZoomRx's commitment to increasing brand performance and maximizing patient impact. We are excited to have Brian lead our rapidly expanding Commercial Analytics practice and look forward to the fresh solutions he will bring to our global life sciences clients.?